The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
there's you know one of the major pathologies of Alzheimer's disease are amyloid plaques in the brain and there are other pathologies Tau Tangles also glucose hypo metabolism so you know glucose uptake into the brain is impaired and also uh perhaps even the utilization of glucose as well so
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
A hallmark characteristic of Alzheimer's disease is glucose hypom metabolism. So that is actually being part of the criteria for evaluating.